Pharma Sessions

Adoption, Insights and Patient Engagement with Pete Piliero, VP Med Affairs at Melinta Therapeutics

September 15, 2022 Season 1 Episode 2
Adoption, Insights and Patient Engagement with Pete Piliero, VP Med Affairs at Melinta Therapeutics
Pharma Sessions
More Info
Pharma Sessions
Adoption, Insights and Patient Engagement with Pete Piliero, VP Med Affairs at Melinta Therapeutics
Sep 15, 2022 Season 1 Episode 2

I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics.

We talk about: 

  • Transitioning from clinical practice to med affairs
  • Changes in how other groups in pharma see med affairs
  • The differences between access and adoption (and how to impact both)
  • Advances in patient engagement and much more

A quick note–the views expressed here are mine and Pete’s, and don’t reflect those of our employers.

At one point I reference the MAPS, Future of Medical Affairs report. You can view the whole report here: https://medicalaffairs.org/future-medical-affairs-2030/


Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

Show Notes

I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics.

We talk about: 

  • Transitioning from clinical practice to med affairs
  • Changes in how other groups in pharma see med affairs
  • The differences between access and adoption (and how to impact both)
  • Advances in patient engagement and much more

A quick note–the views expressed here are mine and Pete’s, and don’t reflect those of our employers.

At one point I reference the MAPS, Future of Medical Affairs report. You can view the whole report here: https://medicalaffairs.org/future-medical-affairs-2030/


Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com